Literature DB >> 15857935

Increasing incidence of Barrett's oesophagus in the general population.

E M van Soest1, J P Dieleman, P D Siersema, M C J M Sturkenboom, E J Kuipers.   

Abstract

BACKGROUND: Barrett's oesophagus (BO) predisposes to oesophageal adenocarcinoma. Epidemiological data suggest that the incidence of BO is rising but it is unclear whether this reflects a true rise in incidence of BO or an increase in detection secondary to more upper gastrointestinal endoscopies performed. This study aimed to examine the changes in BO incidence relative to the number of upper gastrointestinal endoscopies performed in the general population.
METHODS: We conducted a cohort study using the Integrated Primary Care Information database. This general practice research database contains the complete and longitudinal electronic medical records of more than 500,000 persons.
RESULTS: In total, 260 incident cases of BO were identified during the study period. The incidence of BO increased from 14.3/100,000 person years in 1997 (95% confidence interval (CI) 8.6-22.4) to 23.1/100,000 person years (95% CI 17.2-30.6) in 2002 (r2 = 0.87). The number of upper gastrointestinal endoscopies decreased from 7.2/1000 person years (95% CI 6.7-7.7) to 5.7/1000 person years (95% CI 5.4-6.1) over the same time period. This resulted in an overall increase in detected BO per 1000 endoscopies from 19.8 (95% CI 12.0-31.0) in 1997 to 40.5 (95% CI 30.0-53.5) in 2002 (r2 = 0.93). The incidence of adenocarcinoma increased from 1.7/100,000 person years (95% CI 0.3-5.4) in 1997 to 6.0/100,000 person years (95% CI 3.3-10.2) in 2002 (r2 = 0.87).
CONCLUSION: The incidence of diagnosed BO is increasing, independent of the number of upper gastrointestinal endoscopies that are being performed. This increase in BO incidence will likely result in a further increase in the incidence of oesophageal adenocarcinomas in the near future.

Entities:  

Mesh:

Year:  2005        PMID: 15857935      PMCID: PMC1774890          DOI: 10.1136/gut.2004.063685

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  27 in total

1.  Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus.

Authors:  Richard E Sampliner
Journal:  Am J Gastroenterol       Date:  2002-08       Impact factor: 10.864

2.  Increased incidence of adenocarcinomas at the gastro-oesophageal junction in Dutch males since the 1990s.

Authors:  Bas P L Wijnhoven; Marieke W J Louwman; Hugo W Tilanus; Jan-Willem W Coebergh
Journal:  Eur J Gastroenterol Hepatol       Date:  2002-02       Impact factor: 2.566

3.  Predictive factors of Barrett esophagus: multivariate analysis of 502 patients with gastroesophageal reflux disease.

Authors:  G M Campos; S R DeMeester; J H Peters; S Oberg; P F Crookes; J A Hagen; C G Bremner; L F Sillin; R J Mason; T R DeMeester
Journal:  Arch Surg       Date:  2001-11

4.  A multiethnic population-based study of smoking, alcohol and body size and risk of adenocarcinomas of the stomach and esophagus (United States).

Authors:  A H Wu; P Wan; L Bernstein
Journal:  Cancer Causes Control       Date:  2001-10       Impact factor: 2.506

5.  Prevalence of Barrett's esophagus in asymptomatic individuals.

Authors:  Lauren B Gerson; Katerina Shetler; George Triadafilopoulos
Journal:  Gastroenterology       Date:  2002-08       Impact factor: 22.682

6.  Relationship between body mass and gastro-oesophageal reflux symptoms: The Bristol Helicobacter Project.

Authors:  Liam Murray; Brian Johnston; Athene Lane; Ian Harvey; Jenny Donovan; Prakash Nair; Richard Harvey
Journal:  Int J Epidemiol       Date:  2003-08       Impact factor: 7.196

Review 7.  Effect of Helicobacter pylori infection in Barrett's esophagus and the genesis of esophageal adenocarcinoma.

Authors:  Geoffrey W B Clark
Journal:  World J Surg       Date:  2003-07-24       Impact factor: 3.352

8.  Association of prediagnosis endoscopy with stage and survival in adenocarcinoma of the esophagus and gastric cardia.

Authors:  Gregory S Cooper; Zhong Yuan; Amitabh Chak; Alfred A Rimm
Journal:  Cancer       Date:  2002-07-01       Impact factor: 6.860

9.  Rising incidence of reflux oesophagitis in patients undergoing upper gastrointestinal endoscopy.

Authors:  R J L F Loffeld; A B M M van der Putten
Journal:  Digestion       Date:  2003-11-28       Impact factor: 3.216

10.  Personal view: to treat or not to treat? Helicobacter pylori and gastro-oesophageal reflux disease - an alternative hypothesis.

Authors:  A T R Axon
Journal:  Aliment Pharmacol Ther       Date:  2004-02-01       Impact factor: 8.171

View more
  97 in total

Review 1.  The role of obesity in oesophageal cancer development.

Authors:  Elizabeth Long; Ian L P Beales
Journal:  Therap Adv Gastroenterol       Date:  2014-11       Impact factor: 4.409

2.  Proton pump inhibitors and gastric neoplasia.

Authors:  E J Kuipers
Journal:  Gut       Date:  2006-09       Impact factor: 23.059

Review 3.  Secondary prevention of gastric cancer.

Authors:  Massimo Rugge
Journal:  Gut       Date:  2007-12       Impact factor: 23.059

4.  Single aetiology and dual associations of cardiac cancer.

Authors:  Johannes Lenglinger; Margit Eisler; Martin Riegler
Journal:  Gut       Date:  2007-10       Impact factor: 23.059

5.  The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim.

Authors:  Takatsugu Kan; Fumiaki Sato; Tetsuo Ito; Nobutoshi Matsumura; Stefan David; Yulan Cheng; Rachana Agarwal; Bogdan C Paun; Zhe Jin; Alexandru V Olaru; Florin M Selaru; James P Hamilton; Jian Yang; John M Abraham; Yuriko Mori; Stephen J Meltzer
Journal:  Gastroenterology       Date:  2009-05       Impact factor: 22.682

Review 6.  Endotherapy for Barrett's esophagus with high-grade dysplasia and intramucosal carcinoma.

Authors:  Drew B Schembre
Journal:  J Gastrointest Surg       Date:  2009-03-26       Impact factor: 3.452

7.  GERD symptoms in the general population: prevalence and severity versus care-seeking patients.

Authors:  Erica Cohen; Roger Bolus; Dinesh Khanna; Ron D Hays; Lin Chang; Gil Y Melmed; Puja Khanna; Brennan Spiegel
Journal:  Dig Dis Sci       Date:  2014-05-09       Impact factor: 3.199

8.  Waist-to-hip ratio, but not body mass index, is associated with an increased risk of Barrett's esophagus in white men.

Authors:  Jennifer R Kramer; Lori A Fischbach; Peter Richardson; Abeer Alsarraj; Stephanie Fitzgerald; Yasser Shaib; Neena S Abraham; Maria Velez; Rhonda Cole; Bhupinderjit Anand; Gordana Verstovsek; Massimo Rugge; Paola Parente; David Y Graham; Hashem B El-Serag
Journal:  Clin Gastroenterol Hepatol       Date:  2012-12-04       Impact factor: 11.382

9.  Validation of a rodent model of Barrett's esophagus using quantitative gene expression profiling.

Authors:  Daniel S Oh; Steven R DeMeester; Christy M Dunst; Ryutaro Mori; Bethany J Lehman; Hidekazu Kuramochi; Kathleen Danenberg; Peter Danenberg; Jeffrey A Hagen; Parakrama Chandrasoma; Tom R DeMeester
Journal:  Surg Endosc       Date:  2008-09-24       Impact factor: 4.584

Review 10.  MicroRNAs in Barrett's esophagus and esophageal adenocarcinoma.

Authors:  Takatsugu Kan; Stephen J Meltzer
Journal:  Curr Opin Pharmacol       Date:  2009-09-19       Impact factor: 5.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.